Xiang et al. reported that the expression of OXPHOS-associated genes is associated with higher PGC-1α expression; treatment with the PGC-1a inhibitor SR18292 was shown to significantly impair the proliferation and survival of MM cells due to dysfunction in OXPHOS metabolism [54]. This evidence concerns the gene PPARGC1A and Miyoshi myopathy.